Uromigos 팟 캐스트

Uromigos 공개

더

show episodes

Artwork

1
The Uromigos

The Uromigos

1d ago1d ago

주마다+

Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is Chief of Clinical Trials, Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Centre Tom Powles is Director of Barts Cancer Centre, St Bartholomews Hospital and Professor or Genitourinary oncology, Queen Mary University of London

… continue reading

show series

Artwork

1
Episode 319: ASCO 2024: A Preview of GU Data 33:49

1d ago33:49

나중에 재생

나중에 재생

33:49

What to see at the ASCO 2024 Annual Meeting, with Silke Gillessen.

… continue reading

Artwork

1
Episode 318: The Lancet Commission on prostate cancer: planning for a surge in cases 31:59

7d ago31:59

나중에 재생

나중에 재생

31:59

Nick James discusses this paper, which covers broad issues in prostate cancer - including diagnosis and treatment with a focus on the future.

… continue reading

Artwork

1
Episode 317: AUA 2024 Preview with the AUA Secretary 22:16

19d ago22:16

나중에 재생

나중에 재생

22:16

David Penson discusses highlights for the upcoming meeting. He articulates his excitement around the NMIBC data.

… continue reading

Artwork

1
Episode 316: APCCC 2024 Summary with Silke Gillessen 41:11

22d ago41:11

나중에 재생

나중에 재생

41:11

Silke covers key aspects of the meeting, including surgery vs RT, genetic and somatic testing, PSMA imaging and 1st line triplet therapy.

… continue reading

Artwork

1
Episode 315: APCCC 2024 Quickfire - Bone health, hot flashes and gynecomastia in prostate cancer 18:17

24d ago18:17

나중에 재생

나중에 재생

18:17

Chris Sweeney is joined by Matt Smith, Anthony Joshua and Lisa Horvath to discuss the management of these complex issues in advanced prostate cancer.

… continue reading

Artwork

1
Episode 314: APCCC 2024 Cardiovascular risks with hormone therapy in prostate cancer 25:15

24d ago25:15

나중에 재생

나중에 재생

25:15

Thomas Suter and Chuck Ryan discuss identification and management of cardiovascular disease for patients starting therapy for prostate cancer.

… continue reading

Artwork

1
Episode 313: APCCC 2024 Debate - Radiation therapy in advanced disease 35:40

24d ago35:40

나중에 재생

나중에 재생

35:40

Thomas Zilli and Pierre Blanchard discuss this topic from Lugano.

… continue reading

Artwork

1
Episode 312: APCCC 2024 Radiation therapy after surgery for prostate cancer 23:56

24d ago23:56

나중에 재생

나중에 재생

23:56

Jason Efstathiou and Piet Ost discuss the data for and against this approach.

… continue reading

Artwork

1
Episode 311: The Uromigos Paper of the Month - The POUT Trial 36:02

27d ago36:02

나중에 재생

나중에 재생

36:02

Alison Birtle describes adjuvant chemotherapy in bladder cancer.

… continue reading

Artwork

1
Episode 310: Dosing and duration of drugs from a cost perspective 28:28

1M ago28:28

나중에 재생

나중에 재생

28:28

Daniel Goldstein describes his work on this issue.

… continue reading

Artwork

1
Episode 309: EAU24 Checkmate 274 - OS for adjuvant nivolumab in bladder cancer 27:13

1M ago27:13

나중에 재생

나중에 재생

27:13

In this second part, Matt Galsky describes the OS signal data. We also look into the future.

… continue reading

Artwork

1
Episode 308: EAU24 IMVIGOR 011 - Outcome of ctDNA negative patients post-cystectomy 23:09

1M ago23:09

나중에 재생

나중에 재생

23:09

Tom, Brian and Matt Galsky review the screening component of this study, presented at EAU24.

… continue reading

Artwork

1
Episode 307: Bladder-Sparing Approaches Part 2 35:14

2M ago35:14

나중에 재생

나중에 재생

35:14

Michiel Van der Heijden explores the role of radiotherapy and other neoadjuvant and other neoadjuvant combinations to prevent the need for surgery.

… continue reading

Artwork

1
Episode 306: The Uromigos Paper of the Month - Chemo/Nivo as a bladder sparing approach in UC 29:56

2M ago29:56

나중에 재생

나중에 재생

29:56

Matt Galsky describes his phase 2 study looking at gem/cis/nivo followed by nivo in responders. This potentially avoids cystectomy.

… continue reading

Artwork

1
Episode 305: FDA and Oncology Clinical Trials 29:35

2M ago29:35

나중에 재생

나중에 재생

29:35

FDA Deputy Oncology Director Dan Suzman described approaches to oncology trials. Tom asks 3 last questions which annoys Brian more than usual.

… continue reading

Artwork

1
Episode 304: A PSMA CD3 Bispecific T-cell Engager in CRPC 30:43

2M ago30:43

나중에 재생

나중에 재생

30:43

Tanya Dorff describes acapatamab, a prostate-specific membrane antigen (PSMA) CD3 bispecific engager.

… continue reading

Artwork

1
Episode 303: Community GU Oncology 24:16

3M ago24:16

나중에 재생

나중에 재생

24:16

Michael Lattanzi discusses treatment plans and research in the community.

… continue reading

Artwork

1
Episode 302: Part 2- Adjuvant Therapy in solid tumors 34:37

3M ago34:37

나중에 재생

나중에 재생

34:37

Hans Hammers discusses trial design and patient selection in the adjuvant setting.

… continue reading

Artwork

1
Episode 301: Cancer research from a global perspective. 31:06

3M ago31:06

나중에 재생

나중에 재생

31:06

Vania Wisdom, editor of the Lancet, talks about approaches to cancer treatment and research in developing countries

… continue reading

Artwork

1
Episode 300: Adjuvant PD1 Therapy in Solid Tumours 42:15

3M ago42:15

나중에 재생

나중에 재생

42:15

David McDermott discusses melanoma and renal data. We never get to bladder or lung.

… continue reading

Artwork

1
Episode 299: Androgen receptor ligand-directed degrader BMS-986365 36:40

3M ago36:40

나중에 재생

나중에 재생

36:40

Dana Rathkopf describes phase 1 data for the androgen receptor ligand-directed degrader in prostate cancer

… continue reading

Artwork

1
Episode 298: ASCO GU 2024 Highlights 27:15

4M ago27:15

나중에 재생

나중에 재생

27:15

Silke, Tom and Brian cover the bases.

… continue reading

Artwork

1
Episode 297: ASCO GU 2024: CONTACT2 Part 2 - The Aftermath 22:46

4M ago22:46

나중에 재생

나중에 재생

22:46

Neeraj Agarwal addresses the issues raised at the meeting.

… continue reading

Artwork

1
Episode 296: ASCO GU 2024: Novel approaches to QOL and belzutifan 23:58

4M ago23:58

나중에 재생

나중에 재생

23:58

Cris Bergerot describes her modifications of existing QOL models while Tom describes the QOL data from LS005

… continue reading

Artwork

1
Episode 295: ASCO GU 2024: Adjuvant Therapy in Renal Cancer 32:46

4M ago32:46

나중에 재생

나중에 재생

32:46

Pedro Barata summarises his ASCO GU discussion on this topic.

… continue reading

Artwork

1
Episode 294: ASCO GU 2024: Adjuvant Pembrolizumab in Bladder Cancer 33:17

4M ago33:17

나중에 재생

나중에 재생

33:17

Andrea Apolo describes the results of this positive trial.

… continue reading

Artwork

1
Episode 293: ASCO GU 2024: BRCAaway and CONTACT2 22:21

4M ago22:21

나중에 재생

나중에 재생

22:21

Kim Chi discussed the prostate cancer oral session at ASCO GU 2024.

… continue reading

Artwork

1
Episode 292: ASCO GU 2024: HPN328 - A Tri-Specific T Cell Engager in Prostate Cancer 26:04

4M ago26:04

나중에 재생

나중에 재생

26:04

Misha Beltran describes the activity of this novel agent in neuroendocrine prostate cancer.

… continue reading

Artwork

1
Episode 291: ASCO GU 2024: CONTACT2 - Cabozantinib and Atezolizumab in Prostate Cancer 31:15

4M ago31:15

나중에 재생

나중에 재생

31:15

Neeraj Agarwal describes the results of this positive randomised Phase 3 trial.

… continue reading

Artwork

1
Episode 290: ASCO GU 2024 Preview 26:58

4M ago26:58

나중에 재생

나중에 재생

26:58

What to look out for in bladder, prostate and renal cancer at this year's meeting.

… continue reading

Artwork

1
Episode 289: The Uromigos Paper of the Month - TALAPRO2 in Nature Medicine 36:02

4M ago36:02

나중에 재생

나중에 재생

36:02

Karim Fizazi discusses the clinical and biomarker components of this data.

… continue reading

Artwork

1
Episode 288: APCCC #3: Controversies around Radiotherapy 36:29

4M ago36:29

나중에 재생

나중에 재생

36:29

Thomas Zilli discusses controversies around radiotherapy in prostate cancer.

… continue reading

Artwork

1
Episode 287 APCCC: Early Discontinuation of Therapy in HSPC 34:48

5M ago34:48

나중에 재생

나중에 재생

34:48

Silke Gillessen and Betrand Tombal discuss the questions which will address this issue in Lugano in March 2024.

… continue reading

Artwork

1
Episode 286: APCCC Prostate Cancer Meeting Overview 30:22

5M ago30:22

나중에 재생

나중에 재생

30:22

Silke Gillessen discusses this biannual meeting taking place in Lugano in March 2024.

… continue reading

Artwork

1
Episode 285: Holiday Special: Renal Cancer in 2023 26:02

5M ago26:02

나중에 재생

나중에 재생

26:02

Cristina Suarez discusses the year in review.

… continue reading

Artwork

1
Episode 284: Tres amigas: Lo más destacado del cáncer en urología en 2023 37:56

5M ago37:56

나중에 재생

나중에 재생

37:56

Elena Castro, Begoña Valerrama y Cristina Suárez analizan lo más destacado del cáncer en urología en 2023

… continue reading

Artwork

1
Episode 283: Holiday Special: Prostate Cancer in 2023 34:34

5M ago34:34

나중에 재생

나중에 재생

34:34

Tanya Dorff discusses her favourite prostate cancer studies of the year.

… continue reading

Artwork

1
Episode 282: Holiday Special: Bladder Cancer in 2023 38:12

5M ago38:12

나중에 재생

나중에 재생

38:12

Kala Sridhar discusses all the key trials in 2023. She also reveals her favourite Xmas song.

… continue reading

Artwork

1
Episode 281: The Uromigos Paper of the Month - Lu-177 with Pembrolizumab in Prostate Cancer 25:23

5M ago25:23

나중에 재생

나중에 재생

25:23

Rahul Aggarwal describes his phase 1/2 study with only 1 cycle of Lu-177 in CRPC.

… continue reading

Artwork

1
Episode 280: IKCS 2023 Overview 35:24

6M ago35:24

나중에 재생

나중에 재생

35:24

Tian Zhang discusses this fabulous renal cancer meeting. Belzutifan is covered too.

… continue reading

Artwork

1
An apology 1:47

6M ago1:47

나중에 재생

나중에 재생

1:47

Tom and Brian apologise for the unacceptable words and images which were broadcast by hackers during the Uromigos livestream last week. We’re really sorry and will do everything we can to make sure it never happens again.

… continue reading

Artwork

1
Episode 279: Management of IO-resistant RCC at #UromigosLive 2023 1:00:37

7M ago1:00:37

나중에 재생

나중에 재생

1:00:37

Monty Pal, Toni Chouieri, and Tian Zhang join Tom and Brian to discuss CONTACT-03, TiNivo-2, IO-based therapy, and more.Recorded live at Uromigos Live & Unplugged 2023 in Nashville, TN.

… continue reading

Artwork

1
Episode 278: Current and Future Status of Radioligand Therapy at #UromigosLive 2023 39:31

7M ago39:31

나중에 재생

나중에 재생

39:31

Brian is joined by Neeraj Agarwal, Tanya Dorff, Rana McKay, and Michael Morris to review the state of radioligand therapy. The panel examines primary and secondary end points of VISION, current practice patterns, the right way to dose 177Lu-PSMA, PSMAfore, and more.Recorded live at Uromigos Live & Unplugged 2023 in Nashville, TN.…

… continue reading

Artwork

1
Episode 277: NMIBC Discussion at #UromigosLive 2023 44:04

7M ago44:04

나중에 재생

나중에 재생

44:04

Tom is joined by Sam Chang, Sia Daneshmand, and Petros Grivas to discuss new therapies in non-muscle invasive bladder cancer, including those for BCG-refractory NMIBC and the cretostimogene + pembrolizumab combo for BCG-unresponsive NMIBC. Recorded live at Uromigos Live & Unplugged 2023 in Nashville, TN.…

… continue reading

Artwork

1
Episode 276: ESMO 2023 Highlights 49:08

7M ago49:08

나중에 재생

나중에 재생

49:08

Silke Gillessen joins Tom and Brian to give a summary of the meeting,

… continue reading

Artwork

1
Episode 275: Live meeting preview for #UromigosLive 2023 in Nashville 13:30

7M ago13:30

나중에 재생

나중에 재생

13:30

Brian and Tom discuss the benefits and risks of participating in the upcoming meeting . Uncertainty around it’s success are highlighted . Methods of attending remain opaque.

… continue reading

Artwork

1
Episode 274: ESMO 2023 STEAP1/BiTE in CRPC shows promise 19:46

7M ago19:46

나중에 재생

나중에 재생

19:46

Kevin Kelly described a Six-transmembrane epithelial antigen of the prostate 1 (STEAP1) bispecific T cell engager showing activity in a phase 1 trial in prostate cancer.

… continue reading

Artwork

1
Episode 273: ESMO 2023 - Toripalimab and axitinib in clear cell RCC 13:47

7M ago13:47

나중에 재생

나중에 재생

13:47

Toripalimab plus axitinib as first-line treatment option for advanced RCC by Xinan Sheng

… continue reading

Artwork

1
Episode 272: ESMO 2023 - EV302 and CM901 in 1st line bladder cancer 31:32

7M ago31:32

나중에 재생

나중에 재생

31:32

Michiel van der Heijden and Tom discuss EV302 (EVP) and CM901 (chemo/nivo)

… continue reading

Artwork

1
Episode 271: ESMO 2023 - THOR: Erdafitinib in bladder cancer 23:30

7M ago23:30

나중에 재생

나중에 재생

23:30

Yohann Loriot described the 2 Thor randomised phase 3 studies

… continue reading